In meningioma, Önder et al. (2015) used IHC to report a correlation of decreasing cytoplasmic HTRA1 expression with increasing grade and recurrence, proposing its use as a behavioural marker in these tumours [61]. The gene discussed is HTRA1; the disease is meningioma.